# Identification and Treatment of the Liability to Develop Schizophrenia

> **NCT00305474** · PHASE4 · UNKNOWN · sponsor: **Central South University** · enrollment: 100 (estimated)

## Conditions studied

- Schizophrenia

## Interventions

- **DRUG:** Risperidone

## Key facts

- **NCT ID:** NCT00305474
- **Lead sponsor:** Central South University
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2003-12
- **Primary completion:** 2010-01
- **Final completion:** —
- **Target enrollment:** 100 (ESTIMATED)
- **Last updated:** 2009-06-24

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00305474

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00305474, "Identification and Treatment of the Liability to Develop Schizophrenia". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT00305474. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*